KRAS and non-small cell lung carcinoma: Owing to this, Hai et al. have shown that the combined inhibition of WEE1 and mTOR synergistically induced cytotoxicity in KRAS-mutated NSCLC cells and delayed tumor growth in xenograft models without any drug-related toxicity [167].